Press release
Singapore Pharmaceutical Market is expected to Reach USD 1.8 Billion by 2022: Ken Research
• Singapore has developed 2 biomedical hubs namely Biopolis and Tuas Biomedical Park which facilitate the cooperation between public sector research centers with private labs and pharmaceutical manufacturing and production.
• The market is fragmented with multinational companies dominating the space with major focus on research & development activities. Major multinational companies include GSK, Novartis, Roche, Pfizer, Bayer, AstraZeneca, Abbott, Baxter, Maccine and others.
Singapore Pharmaceutical Industry will be led by increased investment in biopharmaceutical manufacturing and growing research & development activities in the space. The best in class research and manufacturing infrastructure will continue to attract foreign investment in the country. For instance, Japan’s Chugai Pharmaceutical, which operates satellite labs throughout Asia, has plans to invest USD 355 million by 2021, to accelerate its research and development (R&D) capabilities in Singapore. Further, Zuellig Pharma who launched its first innovation centre, Zuellig Health Solutions (ZHS), in Singapore in 2017, plans to invest over SGD 50 million over the next five years. Mundipharma plans to start commercial production of antiseptics at its new plant in Singapore in 2019. Apart from innovation in modern medicine, increased demand for pharmaceutical drugs in Asia, which is driven by growing middle class and an ageing population, has increased the market demand for non-essential and therapeutic treatments. The demand for dietary supplements will increase in order to fulfill the nutrition requirement of the people in their busy lifestyle. Due to the prevalence of chronic diseases such as diabetes, heart diseases and others and aging population, revenue from the prescription drugs will continue to occupy the larger share.
The ongoing success of large pharmaceutical companies and increase in biopharmaceutical startups across the country is creating a growing number of new pharma job opportunities in Singapore. Big global drug makers ramp up output and advance automation at their production sites across the country. The opening of new sites such as AbbVie’s biologics manufacturing facility and the ramp up of others including Amgen and Novartis will augment the manufacturing activities of these firms.
The industry will witness a rise in development of technology to support automation and increase productivity. For instance, GSK has been pioneering a technology called continuous manufacturing where instead of making products in batches, materials are constantly added and products removed Emerging Contract Research Organization market, increasing number of mergers & acquisitions coupled with elevating prevalence of chronic and lifestyle diseases will propel Singapore pharmaceutical market revenue in future.
Ken Research in its latest study, “Singapore Pharmaceutical Market Outlook to 2022 - by Prescription & OTC Drugs and by Patented & Generic Drugs”, suggests that demand for pharmaceutical products in the market will continue to grow in Singapore owing to growing public-private partnerships in R&D and clinical trials and expansion of multinational companies in the space.
Key Topics Covered in the Report:
Pharmaceutical Market Size Singapore
OTC Drugs Market Singapore
Prescription Drugs Market Singapore
Patented Drugs Market Singapore
Generics Drug Market Singapore
Singapore Pharmaceutical Industry
Regulations Medicine Market Singapore
New Drug Approvals in Singapore
Value Chain Pharmaceutical Singapore
Competition Singapore Pharmaceutical
Pharmaceutical Manufacturers Singapore
Singapore Pharmaceutical Future
Forecast Revenue Pharmaceutical Singapore
Contract Research Organization Market Singapore
Number of Clinical Trials Singapore
Vitamins and Dietary Supplements Market Singapore
Vitamin Dietary Supplements Market Singapore
CRO Market Regulations Singapore
CRO Market Growth Singapore
Singapore Biopharmaceutical Market
Number of Pharmaceutical Companies Singapore
For more information on the research report, refer to below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/singapore-pharmaceutical-market/149668-91.html
Products Covered
Prescribed Drugs, OTC Drugs, Biopharmaceuticals, Generic Drugs, Branded Medicine, Vitamin and Dietary Supplements, Drug approvals, Drug Pipeline
Companies Covered:
Haw Par Corporation, Beacon Pharmaceuticals, GSK, Singapore, Roche, Singapore, AstraZeneca, Singapore, Lonza, Singapore, Baxter, Singapore, Abbott, Singapore, MSD, Singapore, Sunward Pharmaceutical, Poli Medical, Union Chemicals and Pharmaceuticals Pte Ltd, Schwabe Pharma Asia Pacific Pte Ltd, and Chemical Company of Malaysia Berhad
Related Reports by Ken Research
https://www.kenresearch.com/healthcare/pharmaceuticals/vietnam-pharmaceutical-market/143605-91.html
Currently all patented drugs are imported for local consumption. Widely imported patented drugs include high-value specialty drugs for oncology and diabetes management.
https://www.kenresearch.com/healthcare/pharmaceuticals/indonesia-pharmaceutical-market/143542-91.html
Majority pharmaceutical companies are located in West Java and Jakarta due to favorable tax incentives, well developed infrastructure and greater access to medicinal herbs.
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
0124-4230204
Ken Research is a Global aggregator and publisher of Market intelligence research reports, equity reports, data base directories and economy reports. Our market research reports provides market sizing analysis, insights on promising industry segments, competition, future outlook and growth drivers in the space. The company is engaged in data analytics and aids clients in due-diligence, product expansion, plant setup, acquisition intelligence to all the other gamut of objectives through our research focus.
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, Sector 49 Gurgaon, Haryana - 122001, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Singapore Pharmaceutical Market is expected to Reach USD 1.8 Billion by 2022: Ken Research here
News-ID: 1098855 • Views: …
More Releases from Ken Research Pvt Ltd
Increase in cybercrime results in India Digital Forensic Market to rise, with an …
With the rise in digital threats and cybercrimes, India Digital Forensic Market makes successive changes like integration of Artificial Intelligence, and marking its overall growth.
STORY OUTLINE
Using techniques like Data Recovery, Log Analysis and more, India Digital Forensic Market enhances its Computer Forensics.
Upgrades towards Network and Mobile Forensics are improving in cyber threats prevention, marking its increase in efficiency and security.
With the incorporation of Cloud Based services, advanced methods and easy…
Global Health Insurance market is expected to grow at a CAGR of ~6% by 2028: Ken …
Due to recent pandemic of Covid 19 health insurance market has grabbed growth ensuring economic help to comman man for better health care facilities with easy money handling and increasing awareness especially after COVID 19.
STORY OUTLINE
Launch of new policies, mergers, acquisitions and partnerships to propel growth in future
Covid 19 has a huge impact on the health insurance market on Global level.
Factors, which are responsible for the growth, are the higher…
Exploring the Investment Landscape in the UK Agricultural Equipment Market
Anticipated to achieve a CAGR of approximately 3.5% (2022-2027), the UK's agricultural equipment market expanded between 2014 and 2018, yet faced a significant downturn in 2019-2020 due to COVID-19.
STORY OUTLINE
The investment landscape in the UK agricultural equipment market is diverse, offering a spectrum of opportunities from established manufacturers to startups driving disruptive change.
Investors can benefit from the technological prowess of leading manufacturers like John Deere, CNH Industrial, and AGCO Corporation…
Unveiling the Thriving Landscape of UAE's IT Service Market
The IT services sector encompasses a diverse range of offerings, including but not limited to Cloud services, Cloud Applications, Datacenters, Artificial Intelligence (AI), Consulting Services, Connectivity Solutions, Security services, and other related services.
STORY OUTLINE
Digital Transformation Drive: UAE's IT market thrives on visionary government initiatives like "Smart Dubai" and "UAE Vision 2021," spurring sectoral evolution.
Cloud's Ascendancy: Rapid cloud adoption, coupled with AI, IoT, and blockchain, reshapes industries for scalability and innovation.
Security…
More Releases for Singapore
Singapore Probiotic Food Supplement Market Statistical Forecast, Growth Insights …
Singapore Probiotic Food Supplement Market Research Report By DataM Intelligence: A comprehensive analysis of current and emerging trends provides clarity on the dynamics of the Singapore Probiotic Food Supplement market. The report employs Porter's Five Forces model to assess key factors such as the influence of suppliers and customers, risks posed by different entities, competitive intensity, and the potential of emerging entrepreneurs, offering valuable insights. Additionally, the report presents research…
Singapore Memories: The Pinnacle of Perfumery in Singapore
In the heart of Singapore lies an olfactory haven that has garnered acclaim and admiration from both locals and tourists alike. Singapore Memories, widely celebrated as the best perfume shop in Singapore, continues to captivate scent enthusiasts with its exquisite collection of fragrances that pay homage to the rich cultural heritage and diverse flora of the region.
Unparalleled Perfumery Craftsmanship
Singapore Memories stands out in the competitive landscape of the perfume industry…
Singapore Bunker Fuel Market: Fueling Maritime Commerce | Singapore 3.5% Growing
According to a new report published by Allied Market Research, The Singapore bunker fuel market size was valued at $17.6 billion in 2020, and is projected to reach $24.5 billion by 2030, growing at a CAGR of 3.5% from 2021 to 2030.
Singapore is one of the world's largest bunkering ports and is a significant hub for the supply and trading of bunker fuel. Bunker fuel is a type of fuel…
Payroll services Singapore: Automating Businesses In Singapore Becoming More Pop …
What is payroll
Payroll is the method used to pay employees' salaries. Making a list of the personnel who need to be paid comes first, and recording the expenses comes last. It's a complicated procedure that requires cooperation from numerous teams, including payroll, HR, and finance.
1. Save money on the best payroll processing available.
In order to give you the finest service possible, a payroll services firm is always updating…
Peoplewave selected for Startup Station Singapore by Facebook and IMDA Singapore
20 February 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, has been selected to participate in Startup Station Singapore 2019.
Startup Station Singapore is a partnership between Facebook and the Infocomm Media Development Authority (IMDA) Singapore. Kicking off in February 2019, this programme will empower data-driven startups to accelerate their businesses in new and cutting-edge ways, while continuing to keep peoples’ trust, transparency and control over their data at…
Baby Food Sector in Singapore Global Report 2018: Top Key Players - Abbott Labor …
The Baby Food Sector in Singapore, 2018", is an analytical report by GlobalData which provides extensive and highly detailed current and future market trends in the Singapore market.
The development of the baby food sector in Singapore goes beyond the realms of disposable income and is more often dependent on attitudes to industrially prepared foods in general, the desire for convenient alternatives, and the employment status of women. Baby food manufacturers…
